Phentermine HCL White/Blue Speckled tablets, 37.5 mg, packaged in a) 7-count bags, and b) 28-coun...

FDA Drug Recall #D-1531-2020 — Class II — July 27, 2020

Recall Summary

Recall Number D-1531-2020
Classification Class II — Moderate risk
Date Initiated July 27, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Calvin Scott & Company, Inc.
Location Albuquerque, NM
Product Type Drugs
Quantity N/A

Product Description

Phentermine HCL White/Blue Speckled tablets, 37.5 mg, packaged in a) 7-count bags, and b) 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Lannett Company, Inc. Philadelphia, PA 19136; NDC 00527-1445-10

Reason for Recall

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot # a) and b) 19350; Exp. Date: 1/21

Other Recalls from Calvin Scott & Company, Inc.

Recall # Classification Product Date
D-1123-2022 Class III Benzphetamine tablets, 50mg, CIII, repackaged i... Jan 15, 2021
D-1124-2022 Class I Benzonatate capsules, 100mg, repackaged in 30-c... Jan 15, 2021
D-0010-2021 Class II Diethylpropion, 75 mg tablets, Rx only, Distrib... Sep 16, 2020
D-0009-2021 Class II Diethylpropion, 25 mg tablets, Rx only, Distrib... Sep 16, 2020
D-0011-2021 Class II Phentermine, 30 mg capsules, Rx only, Distribut... Sep 16, 2020

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.